Your browser doesn't support javascript.
loading
Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi, Alberto; D'Ippolito, Emma; Riva, Giulia; Molinelli, Silvia; Gandini, Sara; Viselner, Gisela; Fiore, Maria Rosaria; Vischioni, Barbara; Vitolo, Viviana; Bonora, Maria; Ronchi, Sara; Petrucci, Rachele; Barcellini, Amelia; Mirandola, Alfredo; Russo, Stefania; Vai, Alessandro; Mastella, Edoardo; Magro, Giuseppe; Maestri, Davide; Ciocca, Mario; Preda, Lorenzo; Valvo, Francesca; Orecchia, Roberto.
Afiliação
  • Iannalfi A; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • D'Ippolito E; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Riva G; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Molinelli S; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Viselner G; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Fiore MR; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Vischioni B; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Vitolo V; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Bonora M; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Ronchi S; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Petrucci R; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Barcellini A; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Mirandola A; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Russo S; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Vai A; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Mastella E; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Magro G; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Maestri D; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Ciocca M; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Preda L; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Valvo F; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
  • Orecchia R; Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
Neuro Oncol ; 24(8): 1402-1403, 2022 Aug 01.
Article em En | MEDLINE | ID: mdl-34850206
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Neuro Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Revista: Neuro Oncol Ano de publicação: 2022 Tipo de documento: Article